Collaborating for a Cure
Placing the search for a cure for
HIV/AIDS firmly at the center of its research efforts, amfAR has created the
amfAR Research Consortium on HIV Eradication (ARCHE). This grant program supports
collaborative teams of biomedical researchers exploring strategies for
eradicating HIV infection.
“We’ve seen great strides in our collective
of how HIV could potentially be eradicated.”
—amfAR CEO Kevin Robert Frost.
"amfAR has a long and
successful history of bringing people together to take on the big challenges of
HIV/AIDS," says Dr. Rowena Johnston, amfAR’s vice president and director
of research. "We’re tremendously excited by this consortium. And we’re
confident that this collaborative approach will create a synergy that produces
results that exceed what can be generated in individual laboratories."
Vice President and Director of Research Dr. Rowena Johnston (fourth from left) with several recent ARCHE grantees.
Round 1 ARCHE Research Teams and Their Projects
Round 2 amfAR Consortium Helps Lead Efforts for HIV/AIDS
Round 3 Entering Third Year, amfAR Consortium Gathers
Momentum in Quest for HIV/AIDS Cure
Round 4 amfAR Announces Second Round of Cure-Focused Research Grants in Third Year
grantees meet at the amfAR office to discuss their research.
News and Features
amfAR Symposium Looks to Holy Grail of AIDS
amfAR Ramps Up Investment in HIV Cure Research
ARCHE Researchers Prove the Value of
The Search for a Cure—Why Now?
a Path to a Cure
amfAR Consortium To Speed Search for HIV/AIDS
The Search for a Cure: An Enduring Commitment
amfAR Launches Cure Consortium